Mark Drug Medical Supply Opposes Inclusion of Ostomy and Urological Supplies in Competitive Bidding Program
PubComNonGov
Copyright © Targeted News Service, 2025
Copyright © Targeted News Service, 2025
2025-08-23
Carter Struck
WASHINGTON, Aug. 23 -- Mark Drug Medical Supply has issued a public comment letter to the Centers for Medicare & Medicaid Services (CMS), expressing strong opposition to the proposal to include ostomy and urological supplies in the DMEPOS Competitive Bidding Program (CBP). The organization contends that such inclusion could jeopardize patient care and access to essential medical products.
In the letter, Mark Drug Medical Supply highlights the crucial role that ostomy and urological . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Aug. 23 -- Mark Drug Medical Supply has issued a public comment letter to the Centers for Medicare & Medicaid Services (CMS), expressing strong opposition to the proposal to include ostomy and urological supplies in the DMEPOS Competitive Bidding Program (CBP). The organization contends that such inclusion could jeopardize patient care and access to essential medical products.
In the letter, Mark Drug Medical Supply highlights the crucial role that ostomy and urological . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
